Lithium Dosing for a 15-Year-Old
For a 15-year-old, use adult dosing protocols starting with 12-24 mmol (450-900 mg) of lithium carbonate per day divided into 2-3 doses, targeting serum levels of 0.6-0.8 mmol/L measured 12 hours post-dose. 1
Initial Dosing Strategy
- Start with 450-900 mg daily (12-24 mmol) of lithium carbonate, typically divided into twice-daily or three-times-daily dosing 1
- The specific starting dose within this range depends on body weight, with heavier adolescents requiring doses toward the upper end 1
- Once-daily evening dosing with sustained-release formulations is increasingly recommended for improved compliance, though twice-daily remains well-established 1
Target Therapeutic Range
- Maintain serum concentrations between 0.6-0.8 mmol/L for most indications 1
- Some clinicians still favor 0.8-1.2 mmol/L, but the lower range minimizes side effects while maintaining efficacy 1
- For augmentation of antidepressants, even lower levels (0.2-0.6 mmol/L) may be adequate 2
- Avoid levels >1.5 mmol/L as this increases risk of toxicity affecting kidney, liver, heart, and glands 3
Critical Monitoring Requirements
Baseline Testing (Before Starting)
- Complete blood count 2
- Thyroid function tests (TSH, free T4) 2
- Renal function (BUN, creatinine, GFR) 2
- Serum electrolytes including calcium 2
- Urinalysis 2
- ECG to check for QT prolongation 4
Ongoing Monitoring
- Serum lithium levels drawn 12 hours after the last dose (or 24 hours for once-daily dosing) 1
- Renal function tests every 3-6 months 4
- Thyroid function tests every 3-6 months 4
- Serum calcium annually 4
- Liver function tests at 1 month, then every 6 months 4
Formulation Considerations
- Standard-release formulations reach peak plasma concentration at 1-2 hours with bioavailability of 80-100% 1
- Sustained-release formulations peak at 4-5 hours and reduce peak concentrations by 30-50%, which may improve tolerability 1
- With sustained-release preparations, target the upper therapeutic range (0.8-1.0 mmol/L) rather than 0.6-0.8 mmol/L due to the delayed peak 1
Important Safety Considerations
Early Toxicity Warning Signs
- Tremor, nausea, diarrhea, and polyuria-polydipsia are early indicators of toxicity 4
- Levels >2.0 mmol/L can cause neurological symptoms including cerebellar dysfunction 3
- Prolonged intoxication >2 mmol/L can cause permanent brain damage 3
Drug Interactions and Contraindications
- Avoid NSAIDs as they increase lithium levels and toxicity risk 2
- Significant renal impairment (GFR <60 mL/min/1.73 m²) requires dose reduction and more frequent monitoring 2
- Severe dehydration and sodium depletion are contraindications 2
- Maintain adequate hydration, especially during illness 2
Practical Dosing Algorithm
- Verify no contraindications through baseline laboratory testing 2
- Start with 450-600 mg daily for average-weight adolescents, divided into 2 doses 1
- Check serum level after 5-7 days (5 half-lives to reach steady state, given 18-36 hour half-life) 1
- Adjust dose based on serum level: if below 0.6 mmol/L, increase by 150-300 mg; if above 0.8 mmol/L, decrease by 150-300 mg 1
- Recheck levels 5-7 days after each adjustment until therapeutic range achieved 1
- Once stable, monitor levels monthly initially, then every 3-6 months 4